Heplisav-b

— THERAPEUTIC DISORDERS TREATED —
  • Vaccines

Heplisav-b Generic Name & Formulations

General Description

Hepatitis B vaccine (recombinant), adjuvanted (formulated to contain HBsAg 20mcg + CpG 1018 3000mcg) per 0.5mL dose; soln for IM inj; preservative-free.

Pharmacological Class

HB.

How Supplied

Single-dose vials—1, 5

Manufacturer

Generic Availability

NO

Heplisav-b Indications

Indications

Hepatitis B immunization.

Heplisav-b Dosage and Administration

Adult

Give IM inj in deltoid muscle. ≥18yrs: 2 doses (0.5mL each) 1 month apart.

Children

<18yrs: not established.

Heplisav-b Contraindications

Contraindications

Yeast hypersensitivity.

Heplisav-b Boxed Warnings

Not Applicable

Heplisav-b Warnings/Precautions

Warnings/Precautions

Have appropriate medical treatment available to manage possible anaphylactic reactions. Immunocompromised. Pregnancy. Nursing mothers.

Heplisav-b Pharmacokinetics

See Literature

Heplisav-b Interactions

Interactions

Concomitant immunosuppressants: may get sub-optimal response. Concomitant immune globulin; give separately using different syringes at different inj sites. May interfere with lab tests.

Heplisav-b Adverse Reactions

Adverse Reactions

Local reactions (eg, pain, redness, swelling), fatigue, headache, malaise; anaphylaxis.

Heplisav-b Clinical Trials

See Literature

Heplisav-b Note

Notes

To register pregnant patients, call (844) 443-7734.

Heplisav-b Patient Counseling

See Literature